Clinical Implications of Updated Heart Failure Nomenclature Part 1

Clinical Implications of Updated Heart Failure Nomenclature Part 1

ReachMD Healthcare Image
In this Medical Minute, explore how to apply the updated heart failure nomenclature from the 2022 AHA/ACC guidelines to accurately identify and diagn…

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    In this Medical Minute, explore how to apply the updated heart failure nomenclature from the 2022 AHA/ACC guidelines to accurately identify and diagnose patients with Dr. Lee R Goldberg, Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. 

  • Disclosure of Conflicts of Interest

    Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

    The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

    Lee R. Goldberg, MD, MPH, FACCconsultant/advisor/speaker: Abbott, Viscardia, Zoll/Respircardia.

    The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Daniel Thibodeau, DHSc, MPH, PA-C as noted below: 

    Daniel Thibodeau, DHSc, MPH, PA-C: consultant/advisor/speaker: Arbor Pharmaceuticals.

  • Target Audience

    This program is intended for those healthcare professionals who manage patients with heart failure, including cardiology, internal/family medicine physicians, and advanced practice providers (nurse practitioners or physician associates/physician assistants).

  • Learning Objectives

    Upon completion of this activity, participants should be able to:

    • Discuss the clinical implications of the updated HF staging and classification recommendations
  • Accreditation and Credit Designation Statements

    Joint Accreditation Statement
    In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

    Physician Continuing Medical Education

    CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Nursing Continuing Professional Development

    The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.25 contact hours.

    Physician Assistants/Physician Associates Continuing Education

    Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until March 27, 2024. PAs should only claim credit commensurate with the extent of their participation.

  • Disclaimer

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

  • Provider(s)/Educational Partner(s)

    Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange

  • Commercial Support

    Supported by an educational grant from Merck Sharp & Dohme Corp.

  • Disclosure of Unlabeled Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments



We’re glad to see you’re enjoying Global Cardiology Academy…
but how about a more personalized experience?

Register for free